A 'family group analysis' (Sankaran) evaluation of a triple-blind homoeopathic drug proving of Erythrina Lysistemon 30CH

Abstract

The aim of this analytical study was to determine the effects of the thirtieth centesimal (30CH) potency of the bark of Erythrina Lysistemon on healthy individuals with the subsequent analysis of the proving data obtained according to Sankaran's model! theory of vital sensations and miasms, so that it may be prescribed according to the Law of Similars, as required by homoeopathic science. Thirty-two healthy volunteers who met all the inclusion criteria participated in this study (Appendix A - Suitability for Inclusion). All volunteers were required to sign a consent form (Appendix B). Forty (40) percent (12 of the 32) of the subjects received placebo in a randomised fashion. This was a triple-blind, placebo controlled study where neither the researchers nor the individuals participating in the study knew who received placebo or verum. The provers were unaware of the nature of the substance they were taking and the researchers were unaware of the nature of the substance that they were administrating. The provers recorded their state prior to the administration of the proving substance to establish a baseline from which their state after taking the proving substance was compared (Appendix D - Instructions to Provers). Data collection took the format of a diary or journal in which the provers recorded their symptoms daily and from which the data was later extracted. Data from